Effectiveness of Tribendimidine and Albendazole Against Intestinal Worms
Author Information
Author(s): Peter Steinmann, Xiao-Nong Zhou, Zun-Wei Du, Jin-Yong Jiang, Shu-Hua Xiao, Zhong-Xing Wu, Hui Zhou, Jürg Utzinger
Primary Institution: Swiss Tropical Institute, Basel, Switzerland
Hypothesis
Is tribendimidine more effective than albendazole in treating soil-transmitted helminths and Strongyloides stercoralis?
Conclusion
Tribendimidine is effective against certain intestinal worms and shows promise for further investigation.
Supporting Evidence
- Tribendimidine reduced the prevalence of S. stercoralis from 19.3% to 8.8%.
- Both drugs were highly effective against A. lumbricoides.
- Tribendimidine showed a significant cure rate for Taenia spp. compared to albendazole.
- No significant adverse events were reported for either drug.
- The study was conducted in a village with high rates of intestinal polyparasitism.
Takeaway
This study tested a new medicine called tribendimidine to see if it works better than an old one called albendazole for treating intestinal worms. Both medicines helped, but tribendimidine showed some good results.
Methodology
An open-label randomized trial comparing the efficacy of single doses of tribendimidine and albendazole in treating intestinal helminths.
Potential Biases
The study was open-label, which may introduce bias in reporting outcomes.
Limitations
The study had a lower participation rate and potential biases in sample selection.
Participant Demographics
Participants were aged 5 to 87 years, with a mix of genders and primarily from the Bulang ethnic group.
Statistical Information
P-Value
p=0.001
Confidence Interval
95% CI
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website